![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsors and Collaborators: |
Groningen Research Institute for Asthma and COPD Numico Research Wageningen, the Netherlands |
Information provided by: | Groningen Research Institute for Asthma and COPD |
ClinicalTrials.gov Identifier: | NCT00224432 |
To study the effect of supplementation of a hydrolyzed formula with probiotic bacteria on clinical and immunological parameters in infants with AD with and without CMA and to compare effectiveness of different strains of probiotics.
Condition | Intervention |
Atopic Dermatitis Atopic Eczema Infantile Eczema |
Drug: probiotics: Lactobacillus GG, lactobacillus Rhamnosus |
MedlinePlus related topics: | Allergy Eczema |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
Official Title: | Double-Blind, Parallel, Randomised Study to Investigate the Clinical and Immunological Effects of Oral Administration of Probiotic Bacteria in Infants With Atopic Dermatitis With and Without Cow’s Milk Allergy. |
Estimated Enrollment: | 45 |
Study Start Date: | March 2001 |
Estimated Study Completion Date: | September 2002 |
Ages Eligible for Study: | up to 5 Months |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Term infants fulfilling the Hanifin (1989) criteria for atopic dermatitis
Exclusion Criteria:
• Previous or current use of anti-histamines, oral corticosteroids, probiotics
Netherlands | |||||
Beatrix Children's Hospital, University Medical Center Groningen | |||||
Groningen, Netherlands, 9700 RB |
Groningen Research Institute for Asthma and COPD |
Numico Research Wageningen, the Netherlands |
Principal Investigator: | Eric J Duiverman, MD, PhD | Dept of Pediatric Pulmonology, University Medical Center Groningen, The Netherlands |
Principal Investigator: | Marianne L Brouwer, MD | Dept of Pediatric Pulmonology, University Medical Center Groningen, The Netherlands |
Study ID Numbers: | METc/99/07/116 |
First Received: | September 13, 2005 |
Last Updated: | September 26, 2006 |
ClinicalTrials.gov Identifier: | NCT00224432 |
Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
|
|
|
|
![]() |